Domain interdependence in the biosynthetic assembly of CFTR.

[1]  J. Marshall,et al.  Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis , 1990, Cell.

[2]  M. Welsh,et al.  Maturation and function of cystic fibrosis transmembrane conductance regulator variants bearing mutations in putative nucleotide-binding domains 1 and 2 , 1991, Molecular and cellular biology.

[3]  L. Tsui,et al.  Expression of the cystic fibrosis gene in non-epithelial invertebrate cells produces a regulated anion conductance , 1991, Cell.

[4]  J. Riordan,et al.  Mislocalization of ΔF508 CFTR in cystic fibrosis sweat gland , 1992, Nature Genetics.

[5]  J. Riordan,et al.  Protein kinase A (PKA) still activates CFTR chloride channel after mutagenesis of all 10 PKA consensus phosphorylation sites. , 1993, The Journal of biological chemistry.

[6]  T. Jensen,et al.  Mapping of cystic fibrosis transmembrane conductance regulator membrane topology by glycosylation site insertion. , 1994, The Journal of biological chemistry.

[7]  M. Welsh,et al.  The amino-terminal portion of CFTR forms a regulated CI− channel , 1994, Cell.

[8]  Satoshi Omura,et al.  Degradation of CFTR by the ubiquitin-proteasome pathway , 1995, Cell.

[9]  A. Helenius,et al.  Quality control in the secretory pathway: the role of calreticulin, calnexin and BiP in the retention of glycoproteins with C-terminal truncations. , 1997, Molecular biology of the cell.

[10]  M. Welsh,et al.  Association of domains within the cystic fibrosis transmembrane conductance regulator. , 1997, Biochemistry.

[11]  J. Riordan,et al.  Characterization of polyclonal and monoclonal antibodies to cystic fibrosis transmembrane conductance regulator. , 1998, Methods in enzymology.

[12]  G. Lukács,et al.  Limited proteolysis as a probe for arrested conformational maturation of ΔF508 CFTR , 1998, Nature Structural Biology.

[13]  J. Riordan,et al.  Regulation of CFTR ion channel gating by MgATP , 1998, FEBS letters.

[14]  G. Lukács,et al.  C-terminal Truncations Destabilize the Cystic Fibrosis Transmembrane Conductance Regulator without Impairing Its Biogenesis , 1999, The Journal of Biological Chemistry.

[15]  J. Riordan Cystic fibrosis as a disease of misprocessing of the cystic fibrosis transmembrane conductance regulator glycoprotein. , 1999, American journal of human genetics.

[16]  J. Riordan,et al.  Removal of multiple arginine-framed trafficking signals overcomes misprocessing of delta F508 CFTR present in most patients with cystic fibrosis. , 1999, Molecular cell.

[17]  J. Riordan,et al.  The non‐hydrolytic pathway of cystic fibrosis transmembrane conductance regulator ion channel gating , 2000, The Journal of physiology.

[18]  J. Riordan,et al.  Differential Interactions of Nucleotides at the Two Nucleotide Binding Domains of the Cystic Fibrosis Transmembrane Conductance Regulator* , 2001, The Journal of Biological Chemistry.

[19]  J. Riordan,et al.  Localization of Sequences within the C-terminal Domain of the Cystic Fibrosis Transmembrane Conductance Regulator Which Impact Maturation and Stability* , 2001, The Journal of Biological Chemistry.

[20]  D. Cyr,et al.  From the cradle to the grave: molecular chaperones that may choose between folding and degradation , 2001, EMBO reports.

[21]  John F Hunt,et al.  Cooperative, ATP-dependent Association of the Nucleotide Binding Cassettes during the Catalytic Cycle of ATP-binding Cassette Transporters* , 2002, The Journal of Biological Chemistry.

[22]  John F Hunt,et al.  ATP binding to the motor domain from an ABC transporter drives formation of a nucleotide sandwich dimer. , 2002, Molecular cell.

[23]  P. Borst,et al.  Mammalian ABC transporters in health and disease. , 2002, Annual review of biochemistry.

[24]  J. Riordan,et al.  Functional analysis of the C-terminal boundary of the second nucleotide binding domain of the cystic fibrosis transmembrane conductance regulator and structural implications. , 2002, The Biochemical journal.

[25]  B. Schwappach,et al.  14-3-3 Dimers Probe the Assembly Status of Multimeric Membrane Proteins , 2003, Current Biology.

[26]  J. Riordan,et al.  Purification and Crystallization of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)* , 2004, Journal of Biological Chemistry.

[27]  B. Papsin,et al.  Misfolding diverts CFTR from recycling to degradation , 2004, The Journal of cell biology.

[28]  Geoffrey J. Barton,et al.  The Jalview Java alignment editor , 2004, Bioinform..

[29]  J. Riordan,et al.  COPII-dependent export of cystic fibrosis transmembrane conductance regulator from the ER uses a di-acidic exit code , 2004, The Journal of cell biology.

[30]  D. Clarke,et al.  The ΔF508 Mutation Disrupts Packing of the Transmembrane Segments of the Cystic Fibrosis Transmembrane Conductance Regulator* , 2004, Journal of Biological Chemistry.

[31]  J. Riordan,et al.  Endocytic trafficking routes of wild type and DeltaF508 cystic fibrosis transmembrane conductance regulator. , 2004, Molecular biology of the cell.

[32]  R. Schekman,et al.  Bi-directional protein transport between the ER and Golgi. , 2004, Annual review of cell and developmental biology.

[33]  J. Kelly,et al.  The Biological and Chemical Basis for Tissue-Selective Amyloid Disease , 2005, Cell.

[34]  Paola Vergani,et al.  CFTR channel opening by ATP-driven tight dimerization of its nucleotide-binding domains , 2005, Nature.

[35]  Kai Du,et al.  The ΔF508 cystic fibrosis mutation impairs domain-domain interactions and arrests post-translational folding of CFTR , 2005, Nature Structural &Molecular Biology.

[36]  J. M. Sauder,et al.  Impact of the ΔF508 Mutation in First Nucleotide-binding Domain of Human Cystic Fibrosis Transmembrane Conductance Regulator on Domain Folding and Structure* , 2005, Journal of Biological Chemistry.

[37]  I. Braakman,et al.  Folding of CFTR is predominantly cotranslational. , 2005, Molecular cell.

[38]  Chad A Brautigam,et al.  Side chain and backbone contributions of Phe508 to CFTR folding , 2005, Nature Structural &Molecular Biology.

[39]  J. Riordan,et al.  F508del CFTR with two altered RXR motifs escapes from ER quality control but its channel activity is thermally sensitive. , 2006, Biochimica et biophysica acta.

[40]  Lutz Schmitt,et al.  A structural analysis of asymmetry required for catalytic activity of an ABC‐ATPase domain dimer , 2006, The EMBO journal.

[41]  C. Fan,et al.  Sequential Quality-Control Checkpoints Triage Misfolded Cystic Fibrosis Transmembrane Conductance Regulator , 2006, Cell.

[42]  G. Tusnády,et al.  Membrane topology of human ABC proteins , 2006, FEBS letters.

[43]  J. Riordan,et al.  The role of cystic fibrosis transmembrane conductance regulator phenylalanine 508 side chain in ion channel gating , 2006, The Journal of physiology.